Postdoctoral Researchers:Heather Bowling is currently a postdoctoral associate studying the role of de novo translation in Autism spectrum disorders using neuroproteomic techniques. She received her Ph.D. from the NYU School of Medicine and her graduate work focused on protein synthesis signaling and subsequent proteomic changes underlying ameliorative neural stimuli. Previously, she worked as a Research Assistant at the Spinal Muscular Atrophy Foundation, which has a therapeutic-driven focus through the combination of basic, clinical, and translational projects. In addition, Heather holds honors for her undergraduate work in Rett syndrome at Wellesley College, and a 2014 SfN Chapter Travel Award. Email: email@example.com Philip Giannopoulos is a neuroscientist interested in the translational role in learning and memory pertaining to aging and autism spectrum disorders. Currently he is working on pathways involved in energy homeostasis and translation in Fragile X Syndrome which is a major form of inherited intellectual disability characterized by a series of physical, cognitive, and emotional symptoms . Phillip received his PhD in Pharmacology with a concentration in Neuroscience with Dr. Domenico Pratico at Temple University exploring the role of lipoxygenases in mechanisms of neurodegeneration related to the pathogenesis of Alzheimer's Disease and related tauopathies. Email: firstname.lastname@example.org Magdalena Kawolinska is a postdoctoral associate examining S6K signaling in NPCs/ iPSCs derived from FXS patients. Magdalena earned her BS from Cleveland State University, Cleveland OH and PhD from Albert Einstein College of Medicine, Bronx NY. Email: email@example.com Francesco Longo is a post-doc interested in understanding the synaptic and behavioral abnormalities associated with autism spectrum disorder, with particular attention to striatal dysfunction in fragile X syndrome model mice. He received his MSc and his PhD in Molecular Pharmacology and Oncology at the Institute for Higher Studies of the University of Ferrara exploring the role of LRRK2 kinase activity in mouse model of model of familial Parkinson’s disease and performing studies focused on the phenomena underlying neurodegeneration. Email: firstname.lastname@example.org
Emanuela Santini is an associate research scientist. Emanuela is interested in understanding the neurobiology of repetitive, stereotyped and perseverative behaviors in the context of Autism Spectrum Disorder (ASD). She is currently studying how alterations in structural and synaptic plasticity at the level of the corpus striatum result in the generation of repetitive, stereotyped and perseverative behaviors in animal models of ASD characterized by dysregulated cap-dependent protein synthesis. In 2014 Emanuela received a NIH, K99/R00 Pathway to Independence Award to continue her research in ASD. After completing her M.Sc. (2004) in Neuroscience at La Sapienza University (Rome, Italy) Laurea summa cum laude, Emanuela earned a Ph.D. (2009) in Medical Science at the Karolinska Institute (Stockholm, Sweden) in the laboratory of Dr. Gilberto Fisone. During the doctoral training she studied the molecular mechanisms of L-DOPA induced dyskinesia, one of the most debilitating side effects of dopamine replacement therapy in Parkinson’s Disease.
Email: email@example.comPrerana Shrestha is a postdoctoral associate studying the role of translation in specific cell types in amygdala for fear related memory processes. She is currently developing a novel chemogenetic approach to inducibly block de novvo protein synthesis in a cell autonomous manner. Prerana received her Ph.D. in Neuroscience at the Rockefeller University in the laboratory of Dr. Nathaniel Heintz. For her dissertation, Prerana developed several bacTRAP transgenic mouse lines to characterize molecularly distinct cortical pyramidal cell types, and focused on layer 2/3 pyramidal cell population in the prefronal cortex that moderate stress induced depression related behavior. She earned her undergraduate degree in Biochamistry, Magna cum laude, from Bates College, Maine. Email: firstname.lastname@example.org Andrew Varga is an Independent Investigator. Dr. Varga has a longstanding interest in mechanisms of learning and memory and the role of sleep in memory consolidation. He has an active research program both on the systems level in human subjects and on the molecular level in collaboration with Dr. Eric Klann at NYU's Center for Neural Science. His clinical interests involve all areas of sleep medicine with particular interest in movement disorders in sleep (RLS, REM Behavior Disorder), sleep in neurodegenerative diseases (such as Alzheimer Disease and Parkinson Disease), and generalized cognitive deficits as a function of fragmented sleep. Email: email@example.com